InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Kabeer Aziz, Director,TenPercentOwner, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 11 open-market SEC Form 4 transactions: 1 purchase worth $2.5M and 10 sales worth $3.3M, reported from Mar 29, 22 to Jan 16, 24. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 16, 24 | ANTXAN2 Therapeutics, Inc. | SELL | 84.1K | $19.65 | $1.7M |
| Nov 14, 23 | ANTXAN2 Therapeutics, Inc. | SELL | 1.5K | $16.15 | $25K |
| Oct 2, 23 | ANTXAN2 Therapeutics, Inc. | SELL | 4.8K | $16.07 | $77K |
| Sep 29, 23 | ANTXAN2 Therapeutics, Inc. | SELL | 83.3K | $16.28 | $1.4M |
| Sep 28, 23 | ANTXAN2 Therapeutics, Inc. | SELL | 7.2K | $16.11 | $115K |
| Sep 27, 23 | ANTXAN2 Therapeutics, Inc. | SELL | 707 | $16.07 | $11K |
| Sep 13, 23 | ANTXAN2 Therapeutics, Inc. | SELL | 336 | $16.00 | $5K |
| Sep 7, 23 | ANTXAN2 Therapeutics, Inc. | SELL | 2.8K | $16.05 | $46K |
| Sep 6, 23 | ANTXAN2 Therapeutics, Inc. | SELL | 3.2K | $16.02 | $51K |
| Aug 23, 23 | ANTXAN2 Therapeutics, Inc. | SELL | 336 | $16.00 | $5K |
| Mar 29, 22 | ANTXAN2 Therapeutics, Inc. | BUY | 166.7K | $15.00 | $2.5M |